Takeda loses battle to stop Mylan from selling generic gout drug


“We conclude that the district court did not abuse its discretion in denying Takeda’s request for a preliminary injunction. We have considered Takeda’s remaining arguments and find them unpersuasive. For the foregoing reasons, the district court’s denial of Takeda’s request for a preliminary injunction is affirmed.”


Have a story you want USA Herald to cover? Submit a tip here and if we think it’s newsworthy, we’ll follow up on it.

Want guaranteed coverage? We also offer contract journalism here.  Just be sure you’re comfortable giving up editorial control, because our journalists are dogged and will follow the story through to it’s conclusion. The story will be published to our exacting standards, without regard for your preferred slant.

Want to contribute a story? We also accept article submissions — check out our writer’s guidelines here.